These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. A frequent somatic mutation in CD274 3'-UTR leads to protein over-expression in gastric cancer by disrupting miR-570 binding. Wang W; Sun J; Li F; Li R; Gu Y; Liu C; Yang P; Zhu M; Chen L; Tian W; Zhou H; Mao Y; Zhang L; Jiang J; Wu C; Hua D; Chen W; Lu B; Ju J; Zhang X Hum Mutat; 2012 Mar; 33(3):480-4. PubMed ID: 22190470 [TBL] [Abstract][Full Text] [Related]
33. Regulation of PD-L1 expression in a high-grade invasive human oral squamous cell carcinoma microenvironment. Hirai M; Kitahara H; Kobayashi Y; Kato K; Bou-Gharios G; Nakamura H; Kawashiri S Int J Oncol; 2017 Jan; 50(1):41-48. PubMed ID: 27922697 [TBL] [Abstract][Full Text] [Related]
34. [Implications of TCGA Network Data on 2nd Generation Immunotherapy Concepts Based on PD-L1 and PD-1 Target Structures]. Peters I; Tezval H; Kramer MW; Wolters M; Grünwald V; Kuczyk MA; Serth J Aktuelle Urol; 2015 Nov; 46(6):481-5. PubMed ID: 26560846 [TBL] [Abstract][Full Text] [Related]
35. Programmed death-1 (PD-1), programmed death-ligand 1 (PD-L1), and EBV-encoded RNA (EBER) expression in Hodgkin lymphoma. Paydas S; Bağır E; Seydaoglu G; Ercolak V; Ergin M Ann Hematol; 2015 Sep; 94(9):1545-52. PubMed ID: 26004934 [TBL] [Abstract][Full Text] [Related]
36. Targeting programmed cell death ligand 1 by CRISPR/Cas9 in osteosarcoma cells. Liao Y; Chen L; Feng Y; Shen J; Gao Y; Cote G; Choy E; Harmon D; Mankin H; Hornicek F; Duan Z Oncotarget; 2017 May; 8(18):30276-30287. PubMed ID: 28415820 [TBL] [Abstract][Full Text] [Related]
37. Programmed death ligand 1 is expressed by non-hodgkin lymphomas and inhibits the activity of tumor-associated T cells. Andorsky DJ; Yamada RE; Said J; Pinkus GS; Betting DJ; Timmerman JM Clin Cancer Res; 2011 Jul; 17(13):4232-44. PubMed ID: 21540239 [TBL] [Abstract][Full Text] [Related]
38. Prognostic impact of programmed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor-infiltrating lymphocytes in ovarian high grade serous carcinoma. Darb-Esfahani S; Kunze CA; Kulbe H; Sehouli J; Wienert S; Lindner J; Budczies J; Bockmayr M; Dietel M; Denkert C; Braicu I; Jöhrens K Oncotarget; 2016 Jan; 7(2):1486-99. PubMed ID: 26625204 [TBL] [Abstract][Full Text] [Related]
39. The prognostic significance of PD-L1 in bladder cancer. Huang Y; Zhang SD; McCrudden C; Chan KW; Lin Y; Kwok HF Oncol Rep; 2015 Jun; 33(6):3075-84. PubMed ID: 25963805 [TBL] [Abstract][Full Text] [Related]
40. Protein Expression of Programmed Death 1 Ligand 1 and HER2 in Gastric Carcinoma. Oki E; Okano S; Saeki H; Umemoto Y; Teraishi K; Nakaji Y; Ando K; Zaitsu Y; Yamashita N; Sugiyama M; Nakashima Y; Ohgaki K; Oda Y; Maehara Y Oncology; 2017; 93(6):387-394. PubMed ID: 28910818 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]